LDE225 Diphosphate Catalog No.:M9943-10 Bumbacea RS

Bumbacea RS

3D Matrigel Transwell invasion assays demonstrate that 10 μM HTH-01-015 markedly inhibits the invasiveness of U2OS cells in this assay

8(3):e60827

Chemical Name: N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1

PubMed Central PMCID: PMC3901569

LDE225 Diphosphate Catalog No.:M9943-10 Bumbacea RSSonidegib, also known as, erismodegib, LDE225, NVP LDE225, is an orally bioavailable small molecule Smoothened (Smo) antagonist with potential antineoplastic activity. Erismodegib selectively binds to the Hedgehog (Hh) ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway and, so, the inhibition of tumor cells in which this pathway is abnormally activated. It was approved by the FDA for treating basal cell